Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Richmond, VA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Bellingham, WA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Bellingham, WA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Kirkland, WA
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Kirkland, WA
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Madison, WI
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
West Allis, WI
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
West Allis, WI
Click here to add this to my saved trials
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated:  2/2/2017
GSK Investigational Site
mi
from
Nairobi,
Study Of Asthma And Genetics In Patients To Be Treated With Fluticasone Propionate/Salmeterol Or Salmeterol Xinafoate
Randomized, Double-Blind Comparison of Advair 100/50 BID vs Salmeterol BID vs Albuterol QID in Subjects With ARG/ARG Genotype 12 Years of Age and Older With Presistent Asthma on Short-Acting Beta2-Agonists Alone
Status: Enrolling
Updated: 2/2/2017
GSK Investigational Site
mi
from
Nairobi,
Click here to add this to my saved trials
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
Status: Enrolling
Updated:  2/14/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
Status: Enrolling
Updated: 2/14/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
Status: Enrolling
Updated:  2/14/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
Status: Enrolling
Updated: 2/14/2017
Inova Fairfax Hospital
mi
from
Falls Church, VA
Click here to add this to my saved trials
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
Status: Enrolling
Updated:  2/16/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial
Status: Enrolling
Updated: 2/16/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Mouse Allergen and Asthma Intervention Trial
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated:  3/15/2017
Johns Hopkins
mi
from
Baltimore, MD
Mouse Allergen and Asthma Intervention Trial
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated: 3/15/2017
Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Mouse Allergen and Asthma Intervention Trial
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated:  3/15/2017
Boston Children's
mi
from
Boston, MA
Mouse Allergen and Asthma Intervention Trial
Mouse Allergen and Asthma Intervention Trial
Status: Enrolling
Updated: 3/15/2017
Boston Children's
mi
from
Boston, MA
Click here to add this to my saved trials
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated:  3/27/2017
Nemours Children's Clinic
mi
from
Wilmington, DE
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated: 3/27/2017
Nemours Children's Clinic
mi
from
Wilmington, DE
Click here to add this to my saved trials
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated:  3/27/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated: 3/27/2017
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated:  3/27/2017
Nemours Children's Clinic
mi
from
Orlando, FL
Molecular Phenotyping of Asthma in Sickle Cell Disease
Molecular Phenotyping of Asthma in Sickle Cell Disease
Status: Enrolling
Updated: 3/27/2017
Nemours Children's Clinic
mi
from
Orlando, FL
Click here to add this to my saved trials
Pilot Study of Magnesium Infusions in Pediatric Asthma
A Pilot Study of Magnesium Infusions (Drips) for Moderate-to-Severe Pediatric Asthma Exacerbations
Status: Enrolling
Updated:  3/29/2017
Kosair Children's Hospital
mi
from
Louisville, KY
Pilot Study of Magnesium Infusions in Pediatric Asthma
A Pilot Study of Magnesium Infusions (Drips) for Moderate-to-Severe Pediatric Asthma Exacerbations
Status: Enrolling
Updated: 3/29/2017
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Characterization of Placebo Responses in Stable Asthma
Characterization of Placebo Responses in Stable Asthma
Status: Enrolling
Updated:  3/29/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Characterization of Placebo Responses in Stable Asthma
Characterization of Placebo Responses in Stable Asthma
Status: Enrolling
Updated: 3/29/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children
Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children
Status: Enrolling
Updated:  4/10/2017
University of Utah
mi
from
Salt Lake City, UT
Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children
Redesigning Ambulatory Care Delivery to Enhance Asthma Control in Children
Status: Enrolling
Updated: 4/10/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
A Study Comparing Measures of Ventilatory Heterogeneity (VH) in Asthma Patients
Status: Enrolling
Updated:  4/19/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Ventilatory Heterogeneity in Participants With Asthma (MK-0476-513)
A Study Comparing Measures of Ventilatory Heterogeneity (VH) in Asthma Patients
Status: Enrolling
Updated: 4/19/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Home Centered Comprehensive Care (HCCC) for Children With Asthma
Home-Centered Comprehensive Care (HCCC) for Children With Severe Asthma: A Pilot Trial
Status: Enrolling
Updated:  5/3/2017
High Risk Children's Clinic
mi
from
Houston, TX
Home Centered Comprehensive Care (HCCC) for Children With Asthma
Home-Centered Comprehensive Care (HCCC) for Children With Severe Asthma: A Pilot Trial
Status: Enrolling
Updated: 5/3/2017
High Risk Children's Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Genotype Stratified Treatment With Anticholinergic vs. Beta-agonist (Long Acting) and Exacerbations (GABLE)
Status: Enrolling
Updated:  5/5/2017
Massachusetts General Hospital
mi
from
Boston, MA
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Genotype Stratified Treatment With Anticholinergic vs. Beta-agonist (Long Acting) and Exacerbations (GABLE)
Status: Enrolling
Updated: 5/5/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Genotype Stratified Treatment With Anticholinergic vs. Beta-agonist (Long Acting) and Exacerbations (GABLE)
Status: Enrolling
Updated:  5/5/2017
Brigham and Women's Hosp
mi
from
Boston, MA
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
Genotype Stratified Treatment With Anticholinergic vs. Beta-agonist (Long Acting) and Exacerbations (GABLE)
Status: Enrolling
Updated: 5/5/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
WCCT Global, LLC
mi
from
Costa Mesa, CA
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
WCCT Global, LLC
mi
from
Costa Mesa, CA
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
Allied Clinical Research
mi
from
Gold River, CA
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
Allied Clinical Research
mi
from
Gold River, CA
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
Allied Clinical Research
mi
from
Reno, NV
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
Allied Clinical Research
mi
from
Reno, NV
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
Dr. Winder & Associates/Toledo Center for Clinical Research
mi
from
Sylvania, OH
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
Dr. Winder & Associates/Toledo Center for Clinical Research
mi
from
Sylvania, OH
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
The Allergy and Asthma Center of Southern Oregon
mi
from
Medford, OR
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
The Allergy and Asthma Center of Southern Oregon
mi
from
Medford, OR
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
West Houston Clinical Research Services
mi
from
Houston, TX
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
West Houston Clinical Research Services
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated:  5/8/2017
Sylvana Research
mi
from
San Antonio, TX
Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Two-Way Cross-Over, Phase 2a Study to Evaluate the Safety and Bronchodilator Activity of TRN-157 in Stable Mild and Moderate Asthmatics
Status: Enrolling
Updated: 5/8/2017
Sylvana Research
mi
from
San Antonio, TX
Click here to add this to my saved trials
HealtheRx Survey for Pulmonary Research Registry Recruitment
HealtheRx Survey for Pulmonary Research Registry Recruitment
Status: Enrolling
Updated:  5/9/2017
University of Chicago
mi
from
Chicago, IL
HealtheRx Survey for Pulmonary Research Registry Recruitment
HealtheRx Survey for Pulmonary Research Registry Recruitment
Status: Enrolling
Updated: 5/9/2017
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Measurement of FeNO in Young Children With the NIOX VERO
A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode
Status: Enrolling
Updated:  5/11/2017
Arizona Allergy & Immunology Research
mi
from
Gilbert, AZ
Measurement of FeNO in Young Children With the NIOX VERO
A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode
Status: Enrolling
Updated: 5/11/2017
Arizona Allergy & Immunology Research
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Measurement of FeNO in Young Children With the NIOX VERO
A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode
Status: Enrolling
Updated:  5/11/2017
Allergy and Asthma Specialists, PC
mi
from
Blue Bell, PA
Measurement of FeNO in Young Children With the NIOX VERO
A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode
Status: Enrolling
Updated: 5/11/2017
Allergy and Asthma Specialists, PC
mi
from
Blue Bell, PA
Click here to add this to my saved trials
Measurement of FeNO in Young Children With the NIOX VERO
A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode
Status: Enrolling
Updated:  5/11/2017
Allergy Partners of North Texas
mi
from
Dallas, TX
Measurement of FeNO in Young Children With the NIOX VERO
A Randomized, Multi-Center, Single-Visit, Clinical Investigation to Assess the Degree of Agreement and Feasibility of Measuring Exhaled Nitric Oxide in Children, Aged 4-6 Years Old, With the NIOX VERO Using the 6 Second Exhalation Mode as Compared With the 10 Second Exhalation Mode
Status: Enrolling
Updated: 5/11/2017
Allergy Partners of North Texas
mi
from
Dallas, TX
Click here to add this to my saved trials
Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children
Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children
Status: Enrolling
Updated:  5/15/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children
Reducing Asthma Disparities Through School-Based Telemedicine for Rural Children
Status: Enrolling
Updated: 5/15/2017
Arkansas Children's Hospital Research Institute
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Allergy Associates of Tucson
mi
from
Tucson, AZ
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Allergy Associates of Tucson
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Kaiser Permanente Los Angeles
mi
from
Los Angeles, CA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Kaiser Permanente Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Southern California Research Center
mi
from
Mission Viejo, CA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Southern California Research Center
mi
from
Mission Viejo, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Allergy & Asthma Consultants
mi
from
Redwood City, CA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Allergy & Asthma Consultants
mi
from
Redwood City, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Dignity Health Medical Foundation
mi
from
Sacramento, CA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Dignity Health Medical Foundation
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Bensch Research Associates
mi
from
Stockton, CA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Bensch Research Associates
mi
from
Stockton, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Allergy & Asthma Medical Group; Clinical Research Division
mi
from
Walnut Creek, CA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Allergy & Asthma Medical Group; Clinical Research Division
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Colorado Children's Hospital; The Breathing Institute
mi
from
Aurora, CO
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Colorado Children's Hospital; The Breathing Institute
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
IMMUNOe International Research Centers
mi
from
Centennial, CO
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
IMMUNOe International Research Centers
mi
from
Centennial, CO
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Asthma And Allergy Associates, P.C.
mi
from
Colorado Springs, CO
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Asthma And Allergy Associates, P.C.
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
National Jewish Medical and Research Center
mi
from
Denver, CO
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
National Jewish Medical and Research Center
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Abel and Buchheim
mi
from
Miami, FL
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Abel and Buchheim
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Compass Research East, LLC
mi
from
Orlando, FL
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Compass Research East, LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Sarasota Clinical Research
mi
from
Sarasota, FL
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Sarasota Clinical Research
mi
from
Sarasota, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
University of South Florida
mi
from
Tampa, FL
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated:  5/15/2017
Brookstone Clinical Res Ctr
mi
from
Columbus, GA
A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Status: Enrolling
Updated: 5/15/2017
Brookstone Clinical Res Ctr
mi
from
Columbus, GA
Click here to add this to my saved trials